Developed with dermatologists, CeraVe Salicylic Acid Smoothing Cream for Rough & Bumpy Skin is an effective method for improving skin texture that exfoliates and moisturises, while helping to protect the skin’s natural barrier. Containing salicylic acid, this helps to sooth uneven, blemish prone skin as well as containing lactic acid to gently smooth and exfoliate. And to hydrate, this gentle, light weight formula contains hyaluronic acid attracting moisture to the skins surface as well as MVE technology for continual moisturising and exfoliating for up to 24hours. Calming niacinamides and 3 barrier-strengthening ceramides help prevent further moisture loss. 10% UREA, Salicylic Acid and LHA gently exfoliate, for smoother and softer skin in just 3 days.
MOISTURISES & SMOOTHS: Helps to hydrate and smooth rough & bumpy skin. Also suitable for keratosis pilaris
GENTLY EXFOLIATES: Salicylic Acid helps to exfoliate the skin while Hyaluronic Acid and UREA help to retain the skin’s natural moisture
ESSENTIAL CERAMIDES: Contains 3 essential ceramides (1, 3, 6-II) to protect the skin’s natural barrier
ALL DAY HYDRATION: Formulated with patented MVE Technology to release skin nourishing ingredients for up to 24 hours
GENTLE ON SKIN: Free of physical exfoliants, fragrance free & non-comedogenic
DEVELOPED WITH DERMATOLOGISTS
For Dry, Rough & Bumpy Skin
10% UREA, Salicylic Acid and LHA
With ceramides 1, 3 and 6-II to help protect the skin’s natural barrier
Hyaluronic Acid to help retain skin’s natural moisture
Gentle, non-irritating formula
Free of physical exfoliants
Accepted by the National Eczema Association
Aqua/Water, Urea, Cetyl Al Glyceryl Stearate SE, Cetearyl Alcohol, Niacinamide, Butyrospermum Park11 Butter/Shea Butter, C12-13 Alkyl Lactate, PEG-100 Stear, Glycerin, Behentrimonium Methosulfate, Dimethicone, Triacetin, Ceramide NP, Ceramide AP, Ceramide EOP, Cerbomer, Sodium Lactate, Salicylic Acid, Hyaluronate, Cholesterol, Phenoxyacetophenone, Citric Acid, Lactic Acid, Phytosphingosine, Xanthan Gum, Ethylhexylglycerin.